Cadiz (CDZI) Prices 1M Share Common Stock Offering for Proceeds of ~$9.75M
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Cadiz Inc. (Nasdaq: CDZI) announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a price to the public of $9.75 per share. The gross proceeds from this offering are expected to be approximately $9.75 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The net proceeds from this offering, after deducting underwriting discounts and commissions, are anticipated to be approximately $9.26 million. The offering is expected to close on or about December 6, 2016, subject to customary closing conditions. The Company has granted the underwriters a 30-day option to purchase up to an additional 150,000 shares of common stock in connection with the public offering.
The Company expects to use the net proceeds from this offering to fund its final development of the Cadiz Valley Water Conservation, Recovery and Storage Project (the “Cadiz Water Project”) and for general corporate purposes, which may include business development activities, capital expenditures, working capital and general and administrative expenses.
B. Riley & Co., LLC is acting as sole book-runner in the offering.
The shares of common stock described above are being offered by Cadiz pursuant to a registration statement (No. 333-214318) filed by the Company with the Securities and Exchange Commission (“SEC”) that has been declared effective. A preliminary prospectus supplement and accompanying base prospectus related to the offering was filed with the SEC on November 30, 2016 and a final prospectus supplement and accompanying base prospectus related to the offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying base prospectus relating to the offering, when available, may be obtained from B. Riley & Co., LLC, 11100 Santa Monica Blvd., Suite 800 Los Angeles California 90025, or by telephone at (888) 295-0155, or by email at email@example.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herbalife (HLF) Provides Q4, FY17 Guidance in Memorandum for $1.325B Credit Facility; Lowers FY17 Sales Guidance
- HomeStreet (HMST) Announces Finalization of Settlement Agreement with SEC
- Amedica (AMDA) Plans Offering of Common Stock and Warrants
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Related EntitiesB. Riley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!